Drug Database
Back to search

Switzerland· 50018001

Decatylen neo, Lutschtabletten

A dequalinium product containing dequalinii chloridum, cinchocaini hydrochloridum, registered in Switzerland by Acino Pharma AG and dispensed under Swissmedic category D. The same ATC class is registered in 4 of our 19 countries.

Cat D (Swissmedic)ATC R02AA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedDecatylen neo, LutschtablettenATCR02AA02REGISTER NO.50018001PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dequalinii chloridum, cinchocaini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dequalinium is registered in 4 of 19 countries.

Countries holding a registration under ATC R02AA02 (dequalinium), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose
Search dequalinium products by name

Dequalinium · ATC R02AA02

4 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
dequalinii chloridum, cinchocaini hydrochloridum
Manufacturer
Acino Pharma AG
Country
Switzerland (CH)
ATC code
R02AA02
ATC class
Dequalinium
Defined daily dose
1.5 mg, O
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under R02AA02

Dequalinium, as other registers publish it.

All dequalinium products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Estonia · Decatylen
  • Lithuania · Decatylen
  • Latvia · Decatylen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd55dda7-3cd6-4ac5-8d7b-1d3ff17cd309
GET /v1/drugs/bd55dda7-3cd6-4ac5-8d7b-1d3ff17cd309?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about dequalinium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console